Signaling cascades that control adipogenesis are essential in the regulation of body weight and obesity. The adaptor p62 controls pathways that modulate cell differentiation. We report here that p62 2/2 mice develop mature-onset obesity, leptin resistance, as well as impaired glucose and insulin intolerance. The metabolic rate was significantly reduced in p62 2/2 nonobese mice, which displayed increased mRNA levels of PPAR-g and reduced levels of UCP-1 in adipose tissue. Basal activity of ERK was enhanced in fat from nonobese mutant mice. Embryo fibroblasts from p62 2/2 mice differentiated better than the wildtype controls into adipocytes, which was abrogated by pharmacological inhibition of the ERK pathway. p62 is induced during adipocyte differentiation and inhibits ERK activation by direct interaction. We propose that p62 normally antagonizes basal ERK activity and adipocyte differentiation and that its loss leads to the hyperactivation of ERK that favors adipogenesis and obesity.
Introduction
The understanding of the signaling pathways that regulate adipocyte growth and differentiation have been the matter of intense research because they would provide new therapeutic opportunities for the treatment of obesity, a worldwide pathological process leading to atherosclerosis and cardiovascular diseases as well as type 2 diabetes (Flier, 2004) . Recent molecular studies are beginning to unravel the signal transduction cascades that go awry during the onset of obesity and that presumably are the causative agents of the disease. Leptin, insulin, and other cytokines and growth factors acting peripherally or centrally play relevant roles in the genesis of obesity and/or its complications (Flier, 2004) . In addition, a number of signaling molecules involved in the control of cell growth, differentiation, and apoptosis have been recently implicated in regulating adiposity and obesity in several systems (Fajas et al., 2002; Hirosumi et al., 2002; Kim et al., 2004; Matsumoto et al., 2003; Molero et al., 2004; Nakae et al., 2003; Suzawa et al., 2003; Um et al., 2004) . We have recently identified p62 as a scaffold protein that serves to locate the atypical PKCs (aPKC; PKCz and PKCl/i) in selective signaling pathways (Sanchez et al., 1998) , conferring specificity to these kinases . In keeping with its scaffold role, p62 consists of a series of modules that interact with relevant signaling proteins. Thus, through its N-terminal AID (OPCA)-containing PB1 region, p62 binds to the homologous PB1 domain of the aPKC, whereas it binds TRAF6 through a relatively small stretch of amino acids located in the central part of the protein (Sanz et al., 2000) . Studies demonstrated that TRAF6 is a critical regulator of osteoclastogenesis and bone remodeling in vivo (Kobayashi et al., 2001; Lomaga et al., 1999) . Interestingly, mutations in the p62 gene have been shown to cause the 5q35-linked Paget's disease of bone, a disorder characterized by aberrant osteoclastic activity (Laurin et al., 2002) . The recent generation in our laboratory of the p62 knockout (KO) mice has revealed that the loss of p62, which although it does not produce major alterations in the basal physiology of bones, clearly produces defects in osteoclastogenesis when mice are challenged with the calciotropic hormone PTHrP, and in vitro when bone marrow osteoclast precursors were activated with RANK-L (Duran et al., 2004) . More recent results from this laboratory demonstrate that as the p62 2/2 mice mature they display a significant increase in bone density (M.T.D.-M. and J.M., unpublished data), consistent with the role of p62 in osteoclast differentiation. We report here that as the p62 KO colony age, these mice become obese and insulin resistant, strongly suggesting that the loss of p62 leads to mature-onset obesity. The detailed biochemical analysis of these mice reveals that the loss of p62 leads to enhanced basal ERK activity that is essential for the control of adipocyte differentiation. These results uncover a novel role for p62 in the control of metabolic pathways leading to obesity and insulin resistance.
Results

Mature-onset obesity in p62
2/2 mice The understanding of the signaling pathways that regulate adipocyte growth and differentiation is essential to identify new therapeutic targets in obesity. The scaffold protein p62 consists of a series of modules that interact with relevant signaling proteins involved in cell growth and differentiation (Duran et al., 2004) . When p62 2/2 mice were compared with wild-type (wt) Figure 1 . Mature-onset obesity in p62 2/2 mice A) Body weight of p62 2/2 (KO) and wt mice at different times, (B and C) photographs showing 10-month-old female wt and p62 ko mice; fat and lean mass of p62 2/2 and wt mice measured by DXA of obese (D) and young male (2-month-old) mice (E and F); (H) food intake, and (G) water intake of wt and p62 2/2 mice at various ages; (I) oxygen consumption of p62 2/2 and wt young male mice. Results are the mean 6 SD of 10 for each genotype.
controls identically treated, no differences were observed in body weight during the first 3 months of age. However, the weight of p62 2/2 mice started to deviate at 4 months of age, and differences become statistically significant at 5 months and remained so until nearly 9 months when the last measurement was performed ( Figure 1A ). At this time point, the p62 2/2 mice were visibly larger than the wt ( Figure 1B) , and upon surgical dissection it was apparent that the p62 2/2 mice have significantly increased body fat ( Figure 1C ). The increase in body fat in mature p62
2/2 mice was also detected by dual X-ray absorptiometry (DXA) ( Figure 1D ). In contrast, changes in fat-free mass (lean) in p62-deficient mice were much less apparent as compared with the wt controls ( Figure 1D ). Interestingly, increased fat content was even found in young, nonovertly obese p62 mutant mice ( Figure 1E ), which show a statistically significant increased percentage of fat and a concomitant reduction in the percentage of lean mass ( Figure 1F ). Food intake was also significantly higher in the p62 2/2 mice ( Figure 1H ), but no differences between wt and mutant mice were observed when the ratio of food intake versus body weight was compared (data not shown). When wt and p62-deficient mice were pair-fed, it became clear that the weight of p62 2/2 mice was higher than that of pair-fed wt controls ( Figure S1A in the Supplemental Data available with this article online), although there were not differences in food intake between both phenotypes ( Figure S1B ). In contrast, water intake was dramatically higher in the p62 2/2 mice from 5-6 months of age as compared to identically treated wt controls ( Figure 1G ), suggesting diabetes and/or insulin resistance. Importantly, the metabolic rate was significantly reduced in p62 2/2 nonobese mice, as indicated by a significant decrease in oxygen consumption as compared to that of wt control mice ( Figure 1I ). The amount of retroperitoneal, interscapular (Figure 2A ), and inguinal (data not shown) fat was significantly higher in mature mutant mice as compared to the wt controls, and adipocytes were also larger in the fat from p62 2/2 mice ( Figure 2B ). Livers of p62 2/2 mice were severely enlarged ( Figure 2C ) with greatly increased fat deposits ( Figure 2D ), consistent with a fatty liver phenotype. p62 2/2 liver weight was 3-fold higher than that of wt. All this suggests that the loss of p62 leads to mature-onset obesity. The size ( Figure 2C ) and cellularity (data not shown) of spleen in p62 2/2 mice were also increased as compared to the wt controls. The spleen from the p62 2/2 mice was also weightier (6-fold) than the wt, as were the heart (2.5-fold) and kidneys (2-fold), but no differences were observed in p62 2/2 brains. Collectively, these results indicate that in addition to obesity, p62 2/2 mice also display overgrowth of at least some tissues but when the percentage of fat versus lean is compared ( Figure 1F ), it is clear that even in young mice the proportion of fat is larger than in wt controls, whereas that of lean is reduced in p62 2/2 mice ( Figure 1F ). Although both males and females become similarly obese when mature (data not shown), however, the increased fat content in young mutant mice was only observed in the male population ( Figures 1E and 1F) but not in the mutant females (data not shown). The reason for this gender difference in young mice are unclear. Preliminary results indicate no differences in locomotor activity when wt and p62-deficient mice were compared (data not shown). Interestingly, obese p62 2/2 mice displayed increased fat TNFa mRNA levels as compared to wt controls ( Figure S2 ), consistent with the notion that obesity leads to the appearance of an inflammatory state (Arkan et al., 2005; Cai et al., 2005) .
Analysis of the messenger RNA levels of genes involved in energy combustion and adipocyte differentiation (Figure 3 ) reveals significantly decreased levels of acyl-CoA oxidase in brown adipose tissue (BAT), and of carnitine palmitoyltransferase-1 in BAT and muscle of the p62 2/2 mice, as well as decreases in UCP-1 and UCP-2 in adipose tissue and of UCP-3 in muscle. In addition, mRNA levels of PGC-1a and b were significantly reduced in the liver of the p62 2/2 mice. Glucose-6-phosphatase mRNA levels were not changed by the loss of p62, whereas those of phophoenolpyruvate carboxykinase were significantly reduced in the liver of the p62 mutant mice. Leptin mRNA levels were unchanged but, interestingly, PPAR-g mRNA levels were increased in WAT from p62-deficient mice. Collectively, these results suggest increased adipogenesis and lower energy expenditure in p62 2/2 mice consistent with the data showing increased fat content ( Figures 1A-1H ) and decreased oxygen consumption ( Figure 1I ) in p62 2/2 mice. These results are even more remarkable if it is taken into account that the tissue samples were obtained from young (2-month-old) nonobese p62-deficient and wt female mice, which at this stage do not show yet changes in the content and percentage of fat, suggesting that the alterations reported here are not secondary to the obese phenotype but seem to be intrinsic to the loss of p62.
Histological analysis of the p62 2/2 pancreas reveals severe islet hyperplasia with some cysts ( Figure S3A ). Immunostaining analysis using anti-insulin antibody indicates increased number of b-cells in p62
2/2 pancreas with no alterations in the number of cells expressing glucagon, somatostatin, and pancreatic peptide. Immunostaining with insulin and glucagon antibodies shows a higher ratio of b-cell to a-cell in the p62 2/2 pancreas ( Figure S3A ). Despite the hyperplastic islets, serum and glucose basal levels were normal in fasting (Table 1 ) but were slightly increased in fed p62
2/2 mice (data not shown). Serum triglyceride and cholesterol levels were dramatically increased, as were the levels of leptin, consistent with the obese phenotype of the p62
mice. An important consequence of obesity is leptin and insulin resistance. In keeping with this, leptin i.c.v. administration in the hypothalamus demonstrates inhibited Stat3 phosphorylation in obese p62 2/2 mice but not in young mutant mice in which the obese phenotype was not apparent yet ( Figure S3B ). Glucose and insulin tolerance tests demonstrate that the loss of p62 impairs glucose and insulin tolerance (Figures S3C and S3D) . In addition, the induction of Srebpc1 in response to refeeding was also inhibited in fat but not in liver of p62 2/2 mice ( Figures  S3E and S3F ). These data indicate that the loss of p62 leads to peripheral insulin resistance. Biochemical data are consistent with this notion. Thus, whereas insulin robustly activates Akt in wt tissues ( Figure S4A ), this parameter is severely abrogated in p62 2/2 muscle and especially fat but not liver ( Figure S4A ). Surprisingly, when S6K activity was determined in the above tissue extracts, the loss of p62 did not impair insulin-activated S6K in fat, liver, or muscle ( Figure S4B ). The degree of tyrosine phosphorylation of IRS-1 in response to insulin injection was severely inhibited in fat ( Figure S4C ) and muscle (data not shown) of p62 2/2 mice as compared to the wt controls. On the other hand, when ERK activity was determined in fat extracts from these mice, it was clear that ERK is potently activated by insulin injection ( Figure S4D ). Importantly, basal ERK activity is dramatically increased in p62-deficient fat to levels comparable to those observed in insulin-injected mice ( Figure S4D ). This enhanced basal ERK activity of p62 mutant mice was specific of the fat p62 and adipogenesis tissue as no similar alterations were detected in muscle or liver (data not shown). These results suggest that the loss of p62 leads to increased basal ERK activity in fat.
Increased ERK activity in the fat of p62 2/2 nonobese mice In order to determine whether these signaling defects were directly related to the lack of p62 or were secondary to the obese phenotype of the mutant mice, young nonobese wt and p62-deficient mice were injected with insulin as above, after which Akt and S6K activities were determined in muscle and fat. Results of Figures 4A-4C show that, in contrast to the data from the p62 2/2 obese mice, Akt activation by insulin is not impaired in muscle or fat of p62-deficient young nonobese mice. In addition, glucose and insulin tolerance tests performed in p62 2/2 nonobese mice revealed that the loss of p62 in young mice does not lead to insulin resistance ( Figure S5 ). This indicates that the insulin resistance observed in the obese p62 2/2 mice is secondary to obesity and is not an intrinsic defect of the p62-deficient muscle or fat. As expected, S6K activation is not affected in muscle or fat from p62 2/2 lean mice (Figures 4A and 4C) . Importantly however, ERK activity in fat of young nonobese p62 mutant mice was clearly enhanced as compared to the wt controls ( Figure 4D ), strongly suggesting that, in contrast to the other parameters, increased ERK activity is an intrinsic property of the p62 2/2 fat independently of the age or the obese state of the mutant mice. The results of Figure 4E indicate that this enhanced ERK activity is not due to increased levels or activity of the insulin receptor in p62-deficient mice. Analysis of the activity of MEK, the upstream regulator of ERK, demonstrates that the loss of p62 does not result in higher but that it shows even reduced phospho-MEK levels ( Figure 4F ), consistent with the existence of a negative feed-back loop from the hyperactivated ERK on MEK. These data strongly suggest that under normal basal conditions p62 exerts a negative influence either directly or indirectly on ERK but not on upstream steps of its activation pathway.
Role of enhanced ERK activity in the increased adipogenesis of p62
2/2 embryo fibroblasts Since PPAR-g mRNA levels were increased in the WAT of p62 2/2 young mice (Figure 3 ), suggesting enhanced adipogenesis, and ERK activity was also increased in the same tissue ( Figure 4D ), and taking into account that ERK has been shown to be important for adipogenesis and obesity (Bost et al., 2005) , we reasoned that the loss of p62 may be provoking increased adipocyte differentiation through ERK what would lead to obesity and insulin resistance. Therefore, we compared the capacity of EFs from p62 2/2 mice with those of wt controls to differentiate into adipocytes in vitro. The results of Figure 5A show that wt EFs have a very limited but detectable ability to become adipocytes in vitro giving a maximal response at 8 days postinduction and declining thereafter. Interestingly, the EFs from the p62 2/2 mice gave rise to a robust adipogenic response detectable at day 8 postinduction, which was further increased at days 10-14. Therefore, the loss of p62 promotes adipogenesis, which may account for the obese phenotype of the p62 2/2 mice and the increased PPARg expression in WAT (see above) and EFs ( Figure S6 ) from these mutant mice. On the other hand, the ectopic expression of p62 into the mutant EFs reduces adipogenesis to wt levels ( Figure 5B , left panel). Quantification of lipid incorporation in these cultures further demonstrates the increased adipogenesis observed in the KO EFs and that this is due to the loss of p62. (Figure 5B , right panel). To determine whether the increased ERK activation may be responsible for that effect, the differentiation culture experiments were carried out in the presence of the MEK inhibitor, PD98159. According to the data of Figure 5C , inhibition of ERK activation severely abolishes the adipogenic response of p62 2/2 EFs demonstrating the important role of ERK in adipocyte differentiation. Data from Figure 5D demonstrate the inhibition of ERK activation by the MEK inhibitor in these cell cultures. 2/2 mice were extracted and the mRNA levels of the different genes were determined by QRT-PCR. ACO, acyl-CoA oxidase; mCPT1, muscle carnitine palmitoyltransferase-1; G6Pase, glucose-6-phosphatase; PEPCK, phophoenolpyruvate carboxykinase. BAT, brown adipose tissue; Li, liver; Mu, muscle; WAT, white adipose tissue. Values are for 7-month wild-type (wt) and p62 2/2 (knockout, KO) mice. Data represent mean 6 SD of five mice of each phenotype. p62 and adipogenesis p62 inhibits ERK function via a sequestration complex In order to understand the mechanism whereby the loss of p62 leads to enhanced ERK activity, we first induced 3T3-L1 cells to differentiate into adipocytes following a standard procedure, and p62 expression was determined at different times thereafter. In parallel, phospho-ERK and ERK levels were determined also at different times during adipocyte differentiation. Of note, p62 protein levels were increased as soon as 30 min after the induction of the adipogenic differentiation program, peaked around 1-6 hr, and remained elevated at least for 12 hr. At 3 days after induction, p62 declined to nearly basal levels ( Figure 6A ). Of potential functional relevance, ERK was maximally activated at 1h followed by a reduction at 6 and 12 hr after induction, which interestingly coincided with the maximal expression of p62 ( Figure 6A ). ERK activity was again significantly increased at 3 days of differentiation, at which time p62 levels were back to basal levels ( Figure 6A ). These results demonstrate that p62 is induced upon adipocyte differentiation and seems to antagonize ERK activation, consistent with the observation in the KO mice and cells. To directly address this possibility, we generated 3T3-L1 cell lines retrovirally transduced with either a control vector or a vector expressing a HA-tagged version of p62. These cells were induced to differentiate as above and phospho-ERK levels were determined. Results from Figure 6B clearly demonstrate that the ectopic expression of p62 ablates ERK activity during adipocyte differentiation. Importantly, this effect results in inhibition of C/EBPb ( Figure 6C ) and PPAR-g ( Figure 6D ) in these cell cultures, consistent with the concept that p62 inhibits adipogenesis by blocking ERK activity. To further support this notion, we generated 3T3-L1 cells with p62 depleted levels by retrovirally transducing shRNA mir for p62 or GFP, as a control. Results of Figure 6E demonstrate the efficient depletion of p62 in the RNA interference cells. Afterwards, p62-depleted or control cells were induced to differentiate and the levels of phospho-ERK were determined. Interestingly, and consistent with our observations in fat from p62 2/2 mice, basal phospho-ERK levels were significantly increased in the p62-depleted as compared to the GFP control cells ( Figure 6F ). Of note, although early activation of ERK is significantly enhanced in the p62-depleted cells ( Figure 6F, upper panel) , the sustained stimulation of ERK detected at days 3 and 6 following differentiation was not specially increased in the p62-depleted cells ( Figure 6F , lower panel). Of note, adipocyte differentiation is significantly accelerated in the p62-depleted 3T3-L1 cells ( Figure 6G) .
We reasoned that a mechanism whereby p62 could be impacting ERK activity and function might involve the direct interaction of both proteins. To address this possibility, 293 cells were transfected with a Myc-tagged p62 expression vector along with a HA-tagged ERK construct, after which cells were stimulated or not with insulin for 7 and 15 min, extracts were prepared and coprecipitation of ERK with p62 was determined. Results of Figure 7A (left panel) show that p62 is in a complex with ERK under basal conditions and that the interaction of both proteins is enhanced upon the insulin challenge. Coimmunoprecipitation control experiments ( Figure 7A, right panel) , demonstrate the specificity of these interactions. We next incubated in vitro translated His-ERK with recombinant bacterially expressed MBP-p62, after which MBP-p62 was recovered in amylose beads, and the associated labeled His-ERK was determined. Interestingly, ERK was able to bind directly MBP-p62 but not MBP alone ( Figure 7B ). When ERK activation is monitored in extracts from 293 cells transfected or not with Myc-p62 along EFs from wt and p62 2/2 (KO) mice were induced to differentiate into adipocytes and stained with Oil Red O (A). KO cells were retrovirally transduced with either a control or a p62 expression vector after which they were induced to differentiate for 14 days and stained as above (B, left panel). Quantification of lipid incorporation by measuring the intensity of Oil Red O in the same cultures (B, right panel). In other experiments (C) p62 2/2 cells were incubated with the selective MEK inhibitor PD98159 and the adipogenesis experiments were performed as above. (D) Immunoblot analysis of extracts demonstrates the inhibition of ERK activity by PD98059 treatment. These are representative experiments from another two with very similar results. p62 and adipogenesis with HA-ERK, it is clear that ERK activation, both endogenous and ectopic, is dramatically inhibited by the expression of p62 ( Figure 7C ). Of note, Myc-p62 expression in 293 cells abrogates the nuclear translocation of phospho-ERK following insulin activation ( Figure 7D ). Again, these results are in keeping with a model according to which the sequestration of ERK by p62 serves to inhibit its enzymatic activity and function. In agreement with this conclusion are the results of the immunofluorescence experiments of Figure 7E . In those studies, 3T3-L1 cells were transfected with Myc-p62 along with HA-ERK (upper panel), after which they were stimulated with insulin and their colocalization was determined by confocal microscopy. As shown in Figure 7E (upper panel), there is a clear colocalization of p62 with ERK in p62 structures (Sanchez et al., 1998) . This observation reinforces the notion that p62 serves to sequester ERK, which leads to the inhibition of its enzymatic activity and function. Interestingly, p62 utilizes a characteristic lysine located in its PB1 domain to interact with acidic residues situated in the PB1s of kinases such as the atypical PKCs or MEK5 (Hirano et al., 2004; Moscat and Diaz-Meco, 2002; Wilson et al., 2003) . ERK has an acidic docking site (Tanoue et al., 2000) that even though is not part of a PB1 domain, resembles the negatively charged amino acids of the PB1s of proteins involved in the interaction with the critical lysine of the PB1 of p62. To determine the role that this lysine might play in the interaction of p62 with ERK, this residue was mutated to alanine to generate the HA-tagged mutant construct p62K7A, which was transfected into 3T3-L1 cells. Of note, whereas wt p62 colocalizes with ERK ( Figure 7E, upper panel) , the mutant protein does not ( Figure 7E , lower panel), strongly suggesting that p62 uses the Figure 6 . Essential role of p62 in adipocyte differentiation and ERK activity in 3T3-L1 preadipocytes (A) 3T3-L1 cells were induced to differentiate into adipocytes following a standard procedure, after which the levels of p62, phospho-ERK, and ERK were determined at different times by immunoblotting. (B) 3T3-L1 cell lines retrovirally transduced with either a control vector or a vector expressing an HA-tagged version of p62 were induced to differentiate as above and phospho-ERK, ERK, and HA-p62 levels were determined. Similar experiments were carried out to determine the levels of C/EBPb (C) by immunoblotting or of PPAR-g mRNA by RT-PCR (D). Depletion of p62 in 3T3-L1 cells retrovirally transduced with shRNA vector for p62 interference (p62i) but not for GFP (GFPi) (E). These cells were induced to differentiate as above and phospho-ERK and ERK levels were determined at different times (F). 3T3-L1 cells p62-depleted by shRNA retroviral transduction as described above were induced to differentiate for 3 and 6 days and PPAR-g protein levels were determined by immunoblot analysis (G). These are representative experiments of at least another two with similar results. basic face of its PB1 domain to sequester ERK. On the other hand, Figure 7F demonstrates that in contrast to what is observed with ERK, MEK does not colocalize with p62. On the other hand, the fact that p62 sequesters ERK but is unable to bind MEK suggests that it may preclude the access of MEK to ERK. In this regard, preliminary data suggest that p62 blocks the ability of MEK to interact with ERK in vitro (data not shown).
Discussion
The results shown here are consistent with a model according to which the loss of p62 results in enhanced ERK activity, increased adipogenesis in vitro, and obesity in vivo. Consistently, p62-deficient obese mice were insulin resistant as determined by glucose intolerance tests, lower hypoglycemic response to insulin, and a dramatic inhibition in the activation of Akt in response to insulin in fat and muscle in vivo. The increased ERK activity observed in the mutant fat is important for the enhanced adipogenesis detected in p62 2/2 EFs, since treatment of these cells with a MEK selective inhibitor during the differentiation process completely abrogates adipogenesis, which is consistent with the proposed role of ERK in adipogenesis in vitro and obesity in vivo (Bost et al., 2005) . The direct interaction of p62 with ERK likely accounts for its role as a negative regulator of ERK 293 cells transfected with a Myc-tagged p62 expression vector along with a HA-tagged ERK construct, were stimulated or not with insulin for 7 and 15 min, extracts were prepared, and coprecipitation of ERK with p62 was determined by immunoblot analysis (A, left panel). As a specificity control, cells were transfected with Myc-p62 either alone (2) or with HA-ERK (+), after which ERK was immunoprecipitated with anti-HA antibody, and the associated Myc-p62 was detected by immunoblotting (A, right panel). In vitro translated His-ERK was incubated with MBP or increasing amounts of MBP-p62, and the ability of ERK to directly bind p62 was determined in pull-down experiments with amylose beads (B). 293 cells transfected with a control vector or with a Myc-p62 expression plasmid along with HA-ERK were stimulated with insulin as above and phospho-HA-ERK, HA-ERK, and endogenous phospho-ERK were determined by immunoblotting (C). 293 cells transfected with or without Myc-p62 were stimulated with insulin for 5 min, after which nuclear extracts were prepared and phosphoERK levels determined by immunoblotting (D). 3T3-L1 cells were transfected with Myc-p62 or Myc-p62 K7A along with HA-ERK, after which they were stimulated with insulin and confocal colocalizations were determined (E). In a parallel experiment, Myc-p62 was cotransfected with HA-MEK, and samples were processed as above (F). These are representative experiments of at least another two with similar results. p62 and adipogenesis activity and function. Interestingly, our results show that although the obese phenotype is observed in mature mutant mice, the first signs of fat accumulation as determined by DXA were already detected in young p62 2/2 male mice, which also show a significant decrease in oxygen consumption as compared with age-matched wt controls. Furthermore, we detected also increased PPAR-g and decreased UCP-1, UCP-2, and UCP-3 mRNA levels in young p62 2/2 mice, which do not yet show signs of fat accumulation by DXA or decreased oxygen consumption. Therefore, the most likely interpretation for our data is that the loss of p62 leads to the activation of a gene program that promotes enhanced adipogenesis and decreased energy expenditure even before the first signs of obesity are overtly detectable. The observations reported here that the loss of p62 leads to enhanced basal ERK activity underlies the biochemical mechanisms responsible for this phenotype, since ERK1-deficient mice are lean, displaying the opposite phenotype to that of p62 2/2 mice. The fact that not only PPAR-g levels are increased in WAT of p62-deficient mice but that also UCP-1 levels are decreased in BAT may suggest that a defect in energy expenditure may also contribute to the phenotype of the p62
mice. This could be interpreted, as that p62 is not only involved in WAT induction but also in BAT function. However, preliminary cell culture experiments do not seem to support a role of p62 in BAT cell differentiation at least in vitro (data not shown), although further studies will be required to fully clarify this question.
It should be taken into account that a number of studies reported that a finely tuned regulation of ERK activity is essential for an adequate control of adipocyte differentiation in in vitro cell culture model systems (Hu et al., 1996) (Kortum et al., 2005) . On the other hand, it has been shown genetically in mice that ERK is necessary for adipogenesis and adiposity in vivo (Bost et al., 2005) . Therefore, ERK actions in this differentiation program must be tightly and temporally controlled since under certain conditions ERK activity may also impair this process through the phosphorylation and consequent inactivation of PPAR-g function, although ERK activity is required for adipogenesis. However, the results of Kortum et al., (2005) demonstrate that supraphysiological activations of ERK between 5 to 14-fold are required for its inhibitory role during adipogenesis in the KSR1-transfected cell in vitro model system. Here we show that p62 plays an essential role in the control of basal ERK activity in vivo and that its inhibition in vitro either pharmacologically or by ectopic expression of p62 severely impairs adipocyte differentiation. In this regard, it should be noted that depletion of p62 by shRNA only affects basal and early activation of ERK but not its late stimulation, which is the one that presumably plays the negative role in adipogenesis (Hu et al., 1996) . The reasons for this selective temporal effects of p62 in this parameter are not totally clear but may be related to the fact that at later times p62 levels are not induced as compared to the amount of p62 observed at early time point following differentiation. Therefore, whereas p62 may play a critical role in the control of basal and early-activated ERK, other p62-independent mechanisms are involved in keeping ERK activity under control. In this regard, it has been reported that later ERK activation is controlled in mature adipocytes by induction of the phosphatase MKP-1 (Sakaue et al., 2004) . Taken together, all these observations suggest that an appropriate control of basal ERK activity is essential for the maintenance of the homeostatic equilibrium in vivo that when disrupted leads to obesity. Consistent with this notion, adipocytes from obese patients with type 2 diabetes have higher ERK basal activity than healthy controls (Carlson et al., 2003) . Intriguingly, high-fat diet stimulates ERK activity specifically in WAT but not in liver or muscle (Bost et al., 2005) . This suggests the existence of cell-type specific functions for ERK and p62 as only fat but not the other tested tissues display enhanced ERK activity in the mutant mice.
It could be argued that the hyperactivation of ERK could also account for the insulin resistance observed in p62 2/2 mice since it has been reported that IRS-1 phosphorylation during ERK activation impairs IRS-1 tyrosine phosphorylation and function (De Fea and Roth, 1997) . However, in young mice in which ERK activity in fat is increased, insulin-induced Akt activation is not impaired. This suggests that enhanced ERK activity in this system does not affect Akt activation and insulin function but that its ability to promote adipogenesis and obesity is the cause of insulin resistance in p62-deficient mice. Another important observation of this study is that S6K activation by insulin is not decreased in p62-deficient fat and muscle. In this regard, recent results from Thomas and coworkers demonstrated that S6K1 2/2 mice have a lean phenotype suggesting that S6K1 may be associated with obesity (Um et al., 2004) . In fact, when obesity is induced in mice fed with a high-fat diet, basal S6K1 activity is significantly increased as compared to mice fed with normal diet (Um et al., 2004) . In addition, the S6K1 2/2 mice show hypersensitivity to insulin in vivo and in vitro and are resistant to diet-induced obesity (Um et al., 2004) . Interestingly, S6K1
2/2 mice show enhanced oxygen consumption and increased UCP1 mRNA levels, the opposite to the phenotype of the p62 2/2 mice. Thus, our results, combined with those of Thomas and coworkers, suggest that p62 and S6K display antagonistic roles in the pathways that control adipogenesis and obesity. It is possible that signals triggered by the obesity produced by the loss of p62, indirectly makes S6K refractory to the inhibitory pathways activated in the insulin-resistant state. In this regard, S6K is regulated by mTor, which is inactivated by the TSC1 and TSC2 tumor suppressors (Inoki et al., 2005; Manning and Cantley, 2003; Nobukini and Thomas, 2004) . Interestingly, recent data suggest that ERK-induced phosphorylation serves to inactivate TSC2 leading to S6K activation (Ma et al., 2005) . Therefore, it is possible that the loss of p62 that leads to the hyperactivation of ERK may further feed in the S6K pathway through TSC2-mTor, impeding its inhibition during insulin resistance. More experiments should be required to fully clarify this question.
In summary, we show here that the loss of p62 in vivo leads to enhanced ERK activation and adipogenesis, which results in obesity and insulin and leptin resistance. Alterations in energy expenditure are also detected in p62-deficient mice. How this contributes to the global obese phenotype of these mutant mice, and its relation to the biochemical alterations in ERK activity reported here, is unclear yet and will require further investigation.
Experimental procedures
Reagents, antibodies, and plasmids Reagents were purchased as follows: leptin was from Preprotech, insulin was from Sigma, and PD98159 was from Calbiochem. Polyclonal anti-phospho-Stat3, anti-phospho-AKT, anti-phospho-MEK, anti-AKT, anti-phospho-S6K, and anti-JNK antibodies were from Cell Signaling. Anti-actin, anti-Stat3, anti-phospho-ERK, anti-MEK, anti-phospho-JNK, anti-phospho-IRb, anti-ERK, anti-HA, anti-Myc, anti-C/EBPb, and anti-S6K antibodies were purchased from Santa Cruz. Anti-insulin, anti-glucagon, and anti-somatostatin were from Dako. Anti-IRb was from Becton Dickinson and anti-PP was from Monosan. Anti-p62 polyclonal antibody was generated and affinity purified in our laboratory. All antibodies were used according to manufacturers' instructions. Expression plasmids for p62 (pcDNA3-Myc-p62; pcDNA3-HA-p62; MBP-p62; pBabe-HA-p62), MEK (CMV-HA-MEK) and ERK (pcDNA1-HA-ERK) have been previously described (Duran et al., 2004) . The K7A p62 mutant was generated by site-directed mutagenesis (QuickChange kit, Stratagene). His-ERK was translated in vitro by the T7-TNT system (Promega). Retroviral shRNA mir in the pSM2c vector specific for mouse p62 were purchased from Openbiosystems.
Mice
The p62 KO mice were described previously (Duran et al., 2004) . All mice were born and kept under pathogen-free conditions. Animal handling protocols conform to the NIH guidelines. Sex-matched 10-month-old mice were used for these studies. For the fasting-refeeding experiment, mice in the fasted group were deprived of food for 24 hr; mice in the refed group were deprived of food for 24 hr, and then allowed access to food for 12 hr before analysis. For leptin i.c.v. injection, after mice were anesthetized, the skull was exposed, and the bregma was located. The right lateral ventricle was injected with 0.5 mg of leptin or buffer in a volume of 3 ml. Glucose-tolerance and insulin-tolerance tests were performed on animals that had been fasted overnight. Animals were injected with either 2 g/Kg body weight of glucose or 0.75 U/Kg body weight of human regular insulin into the peritoneal cavity. Glucose levels were determined in blood collected from the tail tip immediately before and 15, 30, 60, and 120 min after the injection using an Accuchek Advantage glucometer (Roche Diagnostics). Insulin and leptin serum levels were measured by ELISA from Calbiochem and Linco Research, respectively. Cholesterol and triglycerides plasma levels were determined by Labipath.
DXA analysis and energy expenditure measurements DXA measurements in anesthetized mice were performed in an ultra highresolution densitometer PIXImus (GE Medical Systems) following standard procedures. Energy expenditure was evaluated through indirect calorimetry by measuring oxygen consumption with an Oxymax apparatus (Columbus Instruments) over a 16 hr period including the dark phase (Picard et al., 2002) . Spontaneous locomotor activity was measured using individual boxes, each composed with a sliding floor, a detachable cage, and equipped with infra-red captors allowing measurement of ambulatory locomotor activity and rears. Boxes are linked to a computer using an electronic interface (Imetronic, Pessac, France). Mice were tested for 32 hr in order to measure habituation to the apparatus as well as nocturnal and diurnal activities. The quantity of water consumed was measured during the test period using an automated lickometer.
Histology and immunohistochemistry analysis
Adipose tissue, pancreas, and liver were fixed in 10% neutral buffer formalin for 24 hr, dehydrated, and embedded in paraffin. Sections (5 mm) were cut and stained with hematoxylin and eosin or prepared for immunohistochemistry by mounting tissue sections on electrostatically charged slides. Following rehydration, quenching of endogenous peroxidase and blocking in normal serum, tissues were incubated with anti-insulin, anti-glucagon, anti-somatostatin, and anti-PP antibodies overnight at 4ºC, followed by incubation with biotinylated secondary antibody. Antibodies were visualized with avidin-biotin complex (Vectastain Elite, Vector Labs) using diaminobenzidine as a chromagen. Frozen liver sections were also stained with Oil Red O after fixation with PFA.
Western blot
Adipose tissue was lysed by homogenization in modified RIPA buffer (50 mM Tris-Hcl, [pH 7.4], 1% Triton X-100, 0.2% sodium deoxycholate, 0.2% sodium dodecylsulfate (SDS), 1 mM sodium ethylene diamine tetra acetate, 1 mM phenyl methyl sulfonyl fluoride, and protease inhibitors). Other tissues or EFs were lysed in RIPA buffer (13 PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM phenyl methyl sulfonyl fluoride, and protease inhibitors). Lysates were separated by SDS-PAGE and transferred to Nitrocellulose-ECL membranes (Amersham Biosciences) and the immunecomplex was detected by chemiluminescence (Amersham Biosciences).
For coimmunoprecipitation experiments, subconfluent 293 cells were transfected with the different plasmids by the calcium phosphate method, extracts were prepared in lysis buffer (25 mM Tris -HCl [pH 8], 100 mM NaCl, 1% Triton-X100, 10% glycerol, and protease inhibitors), and immunoprecipitations were carried out as previously described (Duran et al., 2004) .
Gene expression analysis
Total RNA was extracted and DNase treated using Nucleospin RNA purification kit from Becton Dickinson. The relative levels of Srebp1c, PPAR-g, and TNF-a mRNAs were determined by real-time quantitative RT-PCR (LigthCycler RNA Amplification Sybr Green, Roche) using actin mRNA for normalization. Primer sequences used are as follows: for Srebp1c: 5 0 -ATCGGCGCG GAAGCTGTCGGGGTAGCGTC-3 0 and 5 0 -ACTGTCTTGGTTGTTGATGAGC TGGAGCAT-3 0 ; for PPAR-g: 5 0 -GAACGTGAAGCCCATCGAGGAC-3 0 and 5 0 -CTGGAGCACCTTGGCGAACA-3 0 ; and for TNF-a: 5 0 -CATCTTCTCAAAA TTCGAGTGACAA-3 0 and 5 0 -TGGGAGTAGACAAGGTACAACCC-3 0 . Expression levels of genes involved in energy combustion and adipocyte differentiation were analyzed in cDNA synthesized from total mRNA using real-time PCR . The sequences of the primer sets used are available at the following URL (http://www-igbmc.u-strasbg.fr/ recherche/Dep_GPSN/Eq_JAuwe/Publi/Paper.html).
Cell culture and adipocyte differentiation EFs were isolated from 13.5 d.p.c. wt or p62 KO embryos and cultured in DMEM supplemented with 10% FCS, 100 U/ml penicillin, 100 mg/ml streptomycin, and 2 mM glutamine. 3T3-L1 were grown in DMEM containing either 10% calf serum (before differentiation) or 10% FBS (during differentiation). Packaging of retrovirus and transduction were performed with pBabe and pBabe-p62 retroviral vectors as described (Duran et al., 2004) . 3T3-L1 cells and p62 KO MEFs were transduced and selected with puromycin. For retroviral transduction of shRNAmir constructs, Linx cells were transfected with Arrest-In transfection reagent (Openbiosystems) to generate virus-containing supernatants. For adipocyte differentiation studies, 3T3-L1 cell lines and EFs were induced to differentiate 2 days after confluence (day 0) with DMEM containing 10% FBS isobutylmethylxantine (0.5 mM), dexamethasone (1 mM), and insulin (10 mg/ml). In some experiments, cells were incubated in the absence or in the presence of the selective MEK inhibitor PD98159 (50 mM). For visualization of differentiated adipocytes, cells were washed with PBS, fixed with PFA 4%, and stained in 0.5% Oil Red O in dextrin, and then rinsed in distilled water for microscopic observation and photography.
Confocal analysis 3T3-L1 and HeLa cells were transfected with Lipofectamine 2000 (Invitrogen). Insulin-treated cells were fixed with 4% formaldehyde and permeabilized with 0.1% Triton X-100. Free aldehyde groups were quenched with 50 mM NH 4 Cl. Endogenous peroxidase activity was quenched by treatment with 3% H 2 O 2 in methanol for 15 min. Fixed cells were blocked in blocking solution. Cells were incubated with the different antibodies (anti-HA and anti-Myc) for 1 hr at 37ºC. The corresponding Alexa-488 or Allexa-594 secondary antibodies were used to directly detect the transfected proteins. Glass cover slips were mounted on mowiol and examined with an MRC 1024 confocal system (Bio-Rad; Richmond, California) mounted on an Axiovert 135 microscope (Zeiss, Oberkochen, Germany).
Supplemental data
Supplemental data include six figures and can be found with this article online at http://www.cellmetabolism.org/cgi/content/full/3/3/211/DC1/.
